Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Cost-effectiveness of an optimised care model for patients with anxiety disorders in primary care
ISRCTN ISRCTN15716049
ClinicalTrials.gov identifier
Public title Cost-effectiveness of an optimised care model for patients with anxiety disorders in primary care
Scientific title Cost-effectiveness of an optimised care model for patients with anxiety disorders in primary care: A cluster randomised controlled trial
Acronym N/A
Serial number at source 93200-061
Study hypothesis Many patients with anxiety disorders do not receive accurate diagnosis or adequate treatment in primary care and cause high medical costs due to costly medical testing or the use of inappropriate and expensive emergency services. The main aim was to analyse the cost-effectiveness of an optimised care model for anxiety disorders in primary care that consisted of an intervention primarily targeted at primary care physicians.
Lay summary
Ethics approval Study protocol was approved by the ethics committee of the University of Leipzig in August 2004
Study design Cluster randomised controlled trial
Countries of recruitment Germany
Disease/condition/study domain Anxiety disorders
Participants - inclusion criteria 1. Patients screened positive for one of the following anxiety disorders according to the criteria of the World Health Organization (WHO) International Classification of Diseases - version 10 (ICD-10):
1.1. Social phobias (F40.1)
1.2. Panic disorder [episodic paroxysmal anxiety] (F41.0)
1.3. Generalized anxiety disorder (F41.1)
1.4. Anxiety disorder, unspecified (F41.9)
Evaluated by German version of the Patient Health Questionnaire (PHQ-D)
2. Between 18 and 65 years of age
Participants - exclusion criteria 1. Terminally ill
2. Suicidal
3. Cognitively impaired
4. Insufficient command of the German language
Anticipated start date 01/08/2005
Anticipated end date 30/04/2007
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet.
Target number of participants 389 respondents at baseline - intervention group (201 patients in 23 practices); control group (188 patients in 23 practices)
Interventions The intervention consisted of a specific training for GPs combined with an offer of consultation to the GPs for specific anxiety patients. The intervention aimed at improving GPs’ diagnostic and therapeutic knowledge and skills through a cognitive behavioural therapy (CBT) approach as used in psychiatry.
Follow-up occurred at 6-months and 9-months.
Primary outcome measure(s) 1. Beck’s Anxiety Inventory (BAI)
2. Direct costs (raised with German Version of Client Sociodemographic and Service Receipt [CSSRI])
Secondary outcome measure(s) 1. WHO Quality of Life Assessment (WHOQOL BREF)
2. Health outcomes questionnaire (EQ-5D)
3. Beck’s Depression Inventory (BDI)
4. Indirect costs (raised with German Version of Client Sociodemographic and Service Receipt [CSSRI])
Sources of funding 1. German Centre for Aerospace (Deutsches Zentrum für Luft- und Raumfahrt e.V.) (ref: DLR/01GL0502)
2. Federal Ministry for Education and Research (Bundeministerium für Bildung und Forschung [BMBF])
Trial website
Publications 1. 2009 results on cost effectiveness in http://www.ncbi.nlm.nih.gov/pubmed/19794198
2. Matschinger H, Roick C, Heider D, Riedel-Heller SG, Surall D, Born A, Angermeyer MC, König HH. Zur Evaluation von cluster-randomisierten Studien durch Wachstumskurven Modelle [To evaluate cluster-randomized trials of growth curve models]. Klinische Diagnostik und Evaluation. 2009 4; 2: 310-326. [Article in German]
3. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20444251
Contact name Prof  Hans-Helmut  König
  Address University of Leipzig
Health Economics Research Unit
Department of Psychiatry
Liebigstr. 26
  City/town Leipzig
  Zip/Postcode 04103
  Country Germany
Sponsor Federal Ministry of Education and Research (Germany)
  Address Projektträger im DLR
Heinrich-Konen-Straße 1
  City/town Bonn
  Zip/Postcode 53227
  Country Germany
  Sponsor website: http://www.dlr.de/pt
Date applied 08/01/2010
Last edited 04/11/2010
Date ISRCTN assigned 17/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central